The potential of PARP as a therapeutic target across pediatric solid malignancies

Abstract Background Pediatric cancer is the leading cause of disease-related death in children and the need for better therapeutic options remains urgent. Due to the limited number of patients, target and drug development for pediatrics is often supplemented by data from studies focused on adult can...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kaylee M. Keller, Joost Koetsier, Linda Schild, Vicky Amo-Addae, Selma Eising, Kim van den Handel, Kimberley Ober, Bianca Koopmans, Anke Essing, Marlinde L. van den Boogaard, Karin P. S. Langenberg, Natalie Jäger, Marcel Kool, Stefan Pfister, M. Emmy M. Dolman, Jan J. Molenaar, Sander R. van Hooff
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-04-01
Series:	BMC Cancer
Assuntos:	PARP Pediatric cancer Synergy Replication stress Ribosomes DNA damage
Acceso en liña:	https://doi.org/10.1186/s12885-022-10319-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!